(Q39872383)

English

Genistein enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitors and inhibits nuclear factor kappa B in nonsmall cell lung cancer cell lines

scientific article published on May 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

Genistein enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitors and inhibits nuclear factor kappa B in nonsmall cell lung cancer cell lines (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

1 reference

based on heuristic

inferred from title

Fazlul H. Sarkar

5

object named as

Fazlul H Sarkar

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

author name string

Shirish M Gadgeel

1

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Shadan Ali

2

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Philip A Philip

3

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Antoinette Wozniak

4

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

language of work or name

0 references

publication date

1 May 2009

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

115

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

2165-2176

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24250

21 January 2018

ErbB-targeted therapeutic approaches in human cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24250

21 January 2018

Deregulated EGFR signaling during lung cancer progression: mutations, amplicons, and autocrine loops

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24250

21 January 2018

Erlotinib in previously treated non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24250

21 January 2018

Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24250

21 January 2018

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24250

21 January 2018

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24250

21 January 2018

Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24250

21 January 2018

Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24250

21 January 2018

Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24250

21 January 2018

ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24250

21 January 2018

Enhanced cytotoxicity induced by gefitinib and specific inhibitors of the Ras or phosphatidyl inositol-3 kinase pathways in non-small cell lung cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24250

21 January 2018

Nuclear factor-kappa B and cancer: its role in prevention and therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24250

21 January 2018

Untangling the ErbB signalling network

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24250

21 January 2018

Tumor dependence on the EGFR signaling pathway expressed by the p-EGFR:p-AKT ratio predicts erlotinib sensitivity in human non-small cell lung cancer (NSCLC) cells expressing wild-type EGFR gene

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24250

21 January 2018

Dietary flavonoids: bioavailability, metabolic effects, and safety

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24250

21 January 2018

Potentiation of the effect of erlotinib by genistein in pancreatic cancer: the role of Akt and nuclear factor-kappaB.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24250

21 January 2018

Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24250

21 January 2018

Response to dual blockade of epidermal growth factor receptor (EGFR) and cycloxygenase-2 in nonsmall cell lung cancer may be dependent on the EGFR mutational status of the tumor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24250

21 January 2018

Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24250

21 January 2018

Cancer chemoprevention with dietary phytochemicals

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24250

21 January 2018

Erlotinib induces mitochondrial-mediated apoptosis in human H3255 non-small-cell lung cancer cells with epidermal growth factor receptorL858R mutation through mitochondrial oxidative phosphorylation-dependent activation of BAX and BAK.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24250

21 January 2018

Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24250

21 January 2018

NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24250

21 January 2018

Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24250

21 January 2018

Molecular predictors of EGFR-TKI sensitivity in advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24250

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24250

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidermal growth factor (EGF) activates nuclear factor-kappaB through IkappaBalpha kinase-independent but EGF receptor-kinase dependent tyrosine 42 phosphorylation of IkappaBalpha

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24250

7 January 2021

based on heuristic

inferred from DOI database lookup

Nuclear factor-kappaB (NF-kappaB) is frequently expressed in lung cancer and preneoplastic lesions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24250

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.24250

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39872383&oldid=2091841392"